Origin allows for the targeted delivery of nitric oxide, produced at the point of therapy from room air, in a vehicle, thermal plasma, which facilitates delivery of the nitric oxide to the specific tissues requiring treatment.
For more details on financing and valuation for Origin, register or login.
Already registered? Click here to log in
To read this article and more news on Origin, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.